Section 708A Notice
Released
Released
Announcement PDF
9 February 2018
Company Announcements Office
Australian Securities Exchange
20 Bridge Street
SYDNEY NSW 2000
Dear Sir/Madam
NOTICE UNDER SECTION 708A OF THE CORPORATIONS ACT
This notice is given by Race Oncology Limited pursuant to section 708A(5)(e) of the Corporations
Act (Act).
The Company has today issued 56,250 fully paid ordinary shares at an issue price of $0.30 per
share (Shares) following the exercise of 56,250 unlisted 30 September 2018 options.
Pursuant to section 708A(5)(e) of the Act, the Company gives notice that:
1. the Company issued the Shares without disclosure to investors under part 6D.2 of the Act;
2. as at the date of this notice, the Company has complied with:
(a) the provisions of Chapter 2M of the Act as they apply to the Company; and
(b) section 674 of the Act; and
3. as at the date of this notice, there is no information that is “excluded information” (as
defined in section 708A(7) of the Act) which is required to be disclosed by the Company.
Yours faithfully
Peter Webse
Company Secretary
Race Oncology Ltd ABN 61 149 318 749
Registered office: L2, 710 Collins St, Docklands VIC Australia 3008
www.raceoncology.com
Share your feedback
Discover